Orphazyme reaches 100 employees – builds sales team before launch
Biotech company Orphazyme is building up a commercial organization and has been actively hiring over the past six months.
BY KEVIN GRØNNEMANN, TRANSLATED BY NIELSINE NIELSEN
Copenhagen-based biotech company Orphazyme is undergoing growing pains, as it is currently building up a commercial organization for the planned launch of the company's pharmaceutical drug arimoclomol next year.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
